Weibo Cao

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Sentinel Lymph Node

Neoadjuvant Chemotherapy

Top Venues

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Xiongfei Li, Fanfan Fan, Xuewang Jia, Lingqi Yang, Jinling He, Quanying Tang, Weibo Cao, Ji Che, Song Xu
Prognosis of unresected versus resected early-stage pulmonary carcinoid tumors ≤3 cm in size: A population-based study. Cancer medicine 13 (11) (2024)
Xiongfei Li, Fanfan Fan, Xuewang Jia, Lingqi Yang, Jinling He, Quanying Tang, Weibo Cao, Ji Che, Song Xu
Prognosis of unresected versus resected early-stage pulmonary carcinoid tumors ≤3 cm in size: A population-based study. Cancer medicine 13 (11) (2024)
Xiongfei Li, Fanfan Fan, Xuewang Jia, Lingqi Yang, Jinling He, Quanying Tang, Weibo Cao, Ji Che, Song Xu
Prognosis of unresected versus resected early-stage pulmonary carcinoid tumors ≤3 cm in size: A population-based study. Cancer medicine 13 (11) (2024)
Xi Lei, Tong Li, Fuling Mao, Fan Ren, Quanying Tang, Weibo Cao, Lingling Zu, Song Xu
Lobe-specific analysis of perioperative chemotherapy for non-small cell lung cancer patients. Cancer medicine (2023)
Weibo Cao, Quanying Tang, Jingtong Zeng, Xin Jin, Lingling Zu, Song Xu
A Review of Biomarkers and Their Clinical Impact in Resected Early-Stage Non-Small-Cell Lung Cancer. Cancers 15 (18) (2023)
Weibo Cao, Haochuan Yu, Shuai Zhu, Xi Lei, Tong Li, Fan Ren, Ning Zhou, Quanying Tang, Lingling Zu, Song Xu
Clinical significance of preoperative neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in the prognosis of resected early-stage patients with non-small cell lung cancer: A meta-analysis. Cancer medicine (2022)